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t i i 
Does a Muscle Strength Index Provide Complementary 
Information to Traditional Disease Activity 
Variables in Patients with Rheumatoid Arthritis? 
G E R O L D S T U C K I , J O S E F S C H Ö N B Ä C H L E R . PIUS B R Ü H L M A N N , S T E F A N M A R I A C H E R . 
T H O M A S S T O L L , and B E A T A . M I C H E L 
A B S T R A C T . Objective. To develop a muscle strength index (MSI) and determine whether it provides complementary 
Information to traditional disease activity variables in patients with rheumatoid arthritis ( R A ) . 
Methods. The M S I was developed on the basis o f practica! and empirical aspects and Statistical 
considerations. Intra and interobserver reliabili ty was assessed on the data from 3 observers on 2 
strength measurements in each of 10 patients. The association o f the M S I with variables of disease 
activity and severity was assessed in univariate analysis. The contribution of the M S I in the explana-
tion of physician's global disease activity after accounting for the effect of traditional measures o f 
disease activity was assessed in multiple linear regression models. 
Results. Eight strength measurements (extension and flexion o f knee and e lbow joints) obtained 
with a hand held pull gauge wcre aggregated into the M S I as the mean o f the standardized scores. 
In 65 patients with R A . the M S I had a high internal consistency (Cronbach 's alpha 0.95) and intra 
and interobserver reliability (Pearson correlation coefficient 0.94 each). The M S I correlated moder-
ately with traditional measures of disease activity and strongly with physical functional disability 
and radiological damage. In contrast to grip strength, the M S I explained additional Variation of phy-
sician's global assessmcnt of disease activity i f added to variables of pooled activity indices. 
Conclusion. The M S I is a reliable and valid measure of disease activity and severity and may improve 
the content validity of pooled disease activity indices. (J Rheumatol 1994,21:2200-5) 
K e y I n d e x i n g T e r m s : 
M U S C L E S T R E N G T H I N D E X M U S C L E S T R E N G T H G R I P S T R E N G T H 
D I S E A S E A C T I V I T Y I N D I C E S R H E U M A T O I D A R T H R I T I S C L I N I M E T R I C S 
The optimal method for assessing disease activity in rheu-
matoid arthritis (RA) remains a matter of debate. Since there 
is no S i n g l e best variable for measuring disease activity, com-
posite indices including laboratory variables, clinical find-
ings and Symptoms have been advocated 1 s . With rcspect to 
examination measurements, there is general agreement on 
the inclusion of an articular index 1 5 . It is striking that no 
other examination measurement has been included in some 
of the most recently developed composite indices of disease 
activity 2 4 . Although the value of grip strength in the long-
term evaluation of individual patients in clinical practice has 
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S w i t z e r l a n d . 
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been appreciatcd\ its inclusion in a disease activity index 
is controversial, and it has been included in few such 
indices'- 5. Major problems with the use of grip strength in 
composite indices for cl inical trials is the difficulty of 
obtaining measurements in patients with significant hand 
deformities". No strength measurement other than grip 
strength has been considered for inclusion in a disease activity 
index. 
Impaired muscle funetion is frequently observed in patients 
with R A and has been attributed to pain, inactivity, psycho-
logical factors, myopathy and d e f o r m i t y 7 H i s t o c h e m i c a l , 
electron microscopic and electromyographic evidence of 
skeletal muscle pathology in patients with R A have been 
p r o v i d e d 1 0 1 2 . His tor ical ly . subjective ordinal scales have 
been used by clinicians to assess muscle strength. Because 
of the insensitivity o f these scales to 20-25% changes in 
muscle strength' 1. a number of devices have been developed 
and teSted for their rel iabil i ty 1 4 . Hand held instruments have 
been of specific interest 1 4 since they are cheap and allow the 
assessment of muscle strength in clinical practice. They may 
be as reliable as fix installed isokinetic measurement instru-
ments (Cybex) 1 4 . 
We hypothesized that muscle strength can be measured 
reliably with a hand held pull gauge and that a muscle strength 
index can provide complementary information to measure-
2 2 0 0 T l i e J o u r n a l o f R h e u m a t o l o g y 1 9 9 4 : 2 1 : 1 2 
ments currently used in pooled indices of disease activity. 
To test these hypotheses, we developed a muscle strength 
index (MSI) and examined its metric propcrties, intra and 
interobserver reliability and validity. W e then examined 
whether the M S I explained additional V a r i a t i o n in disease 
activity after accounting for the effect of a variety of tradi-
tional disease activity measures. 
MATERIALS AND METHODS 
P a t i e n t s . Consecutive patients with R A fulf i l l ing the A m e r i c a n Rheumatism 
Associa t ion ( A C R ) 1987 revised criteria 1-' ' attending the outpatient c l in ic 
of rheumatology. Univers i ty Hospital Z ü r i c h . A n interobserver study was 
performed hy 3 physicians on a subsamplc of patients representing a wide 
spectrum of disease activity twice dur ing one morn ing . 
D a t a c o l l e c t i o n p r o c e d u r e s . A physician performed the strength measure-
ments with a handheld pull gauge. The patient was then evaluated c l i n i -
cal ly by another physician who was unaware o f the strength measurements. 
laboratory tests were performed and radiographs taken. 
M e a s u r e m e n t s . Muscle strength was recorded for the Shoulder, e lbow, wrist, 
hip, knee and ankle Joint. For each Joint but the Shoulder, the measurement 
included extension and f lexion; for the Shoulder, strength o f abduetion and 
adduetion was recorded. For each measurement, the patient was placed in 
a position that excluded the effect of gravity (Figurcs 1 and 2). A nonelastic 
band was connected to a pull gauge wi th a continuous Scale ( r ä n g e 0 - 5 0 
kp, model D P P H . Chatil lon Inc., Grecnsboro. North Carolina) . The observer 
kept the pull gauge in a stable position against a bar. the examinat ion table, 
or his body. The patient was instrueted to increase muscle strength gradu-
ally to his/her l i m it. 
C l i n i c a l Undings recorded were A C R functional class">. swol len and 
tender Joint count, gr ip strength (mean o f both sides), and morning stilf-
ness. Laboratory assessment included erythrocyte Sedimentation rate ( E S R ) , 
F i g . I . Measurement of isometric f lexion and extension strength ot 
C-react ive protein ( C R P ) , hemoglobin (Hb) . S inger-Plo tz titcr. R a d i o l o g i -
cal assessment included radiographs o f the hands and feet; r ad io log ica l 
damage was gracled aecording to the Larsen radiological scoring System 1 7. 
Patient self-report was used for the measurement o f pain [numerical rating 
Scale, 0 - 1 0 ( N R S ) ] . physical functional disabil i ty |health assessment ques-
tionnaire ( H A Q ) 1 " ] and global health (4 point L ike r t scale). O v e r a l l d is -
ease activity was measured as physic ian 's global assessment ( N R S ) and 
through aggregation o f variables in pooled indices [disease act ivi ty score 
( D A S ) 4 , M a l l y a i ndex 1 , V a n R i e l i ndex 1 ] . 
D e v e l o p m e n t o f t h e muscle s t r e n g t h i n d e x . First , the dis t r ibut ion o f each 
muscle measurement was studied. In several patients, muscle sites where 
it was not possible to obtain a strength measurement for anatomical rea-
sons (fusion, pseudoparesis) were excluded from further cons idera t ion . T o 
adjust for the different weight o f the different muscles and to p rov ide an 
interpretable tigure, we t ranslormed the or iginal scores into standardized 
scores by expressing every strength measurement as the percentage o f the 
max ima l strength observed in the sample [(strength obse rved /max imum 
sample strength)* 100): the higher value o f both body sides was used for 
corresponding measurements. A n Overall strength score was then calculat-
ed as the mean o f the individual standardized scores. In the case o f miss ing 
or nonobtainable measurements, this approach has the advantagc that the 
mean can still be calculated from the remaining variables without impor -
tant distortion as long as the number o f measurements ensures stabil i ty o f 
the index. In a next Step, the number o f measurements was reduced. The 
goal was to select enough measurements to maintain sufficient Statistical 
stability and internal consistency as assessed with Cronbach ' s coefficient 
alpha, but to avoid redundancy due to col l inear i ty . In univariate analysis 
(using nonparametric statistics) we evaluated the influence o f patient charac-
teristics such as age. sex. weight and height on the muscle strength indices. 
R e l i a b i l i t y . T o assess intra and interobserver re l iabi l i ty , 3 observers eva lu-
ated 10 patients representing a wide spectrum of disease activity twice dur-
ing one morning. The patients were examined in random Order. In measur-
ing muscle strength, the observers fol lowed a standardized procedura after 
the knee Joint with a pull gauge. 
S t u c k i , et a l : M u s c l e s t r e n g t h i n d e x 2 2 0 1 
F i g . 2. Measurement o f isometric f lexion and extension strength o f the e lbow Joint wi th a pull gauge. 
receiving instructions with respect to ordcr o f measurements and techniques. 
The test-retest re l iabi l i ty (intra and interobserver) o f the muscle measure-
ments was assessed with Pearson's product momcnt correlation coefficient. 
V a l i d i t y . T o assess construct va l id i ty , we tested the hypothesized relation-
ship wi th other disease activi ty variables, pooled disease activity indices 
( D A S , van R i e f M a l l y a ) . physical functional disabi l i ty ( H A Q ) and Joint 
destruct ion (La r sen score). Fo r a l l correlat ions we used Spearman corre la-
tion coefficients to account for the nonnormal distribution o f most variables. 
C o n t r i b u l i o n o f t h e muscle s t r e n g t h i n d e x i n e x p l a i n i n g V a r i a t i o n i n disease 
a c t i v i t y . T o assess the contribution ofthe M S I in explaining disease activity, 
we selected the phys ic ian ' s global disease activi ty assessment to be the 
dependent var iable . In mult iple linear regression models , Controlling for 
age, sex and body height. we examined whether the M S I cxplained addi-
tional Variation in models which contained ar t icular indices (swollen and 
tender Joint count) and E S R or C R P . W e then analyzed whether muscle 
strength cxp la ined additional Variation in models together with variables 
of disease activity index ( D A S : Ri tchic articular index, swollen Joint count, 
E S R , g lobal health; v a n R i e l : morn ing s t i l lness . tender Joint count, 
hemoglob in and E S R ; M a l l y a : morning stiffness, pain, Ritchie articular in-
dex , g r ip strength, hemoglobin and E S R ) . F ina l l y we used gr ip strength 
instead o f the M S I in the above analyses. 
RESULTS 
P a t i e n t s . Sixty-five patients were enrolled in the study. The 
interobserver reliability was assessed on a subsample of 10 
patients. The baseline characteristics of the 65 patients are 
shown in Table 1. 
D e v e l o p m e n t a n d t e s t i n g o f s t r e n g t h i n d i c e s . A l l muscle 
measurements were moderately skewed towards higher 
strength. The strength measurements could not be performed 
for patients lacking mobility in the right wrist (extension: 
5 patients out of 65; flexion: 4/65), the left wrist (extension: 
2/65; flexion 1/65), the right Shoulder (abduetion: 10/65; 
adduetion: 10/65) and the left Shoulder (abduetion: 9/65; ad-
duetion: 9/65). A l l the other muscles had no or one nonob-
tainable measurement. Shoulder and wrist were thus excluded 
T a b l e 1 . B a s e l i n e d e m o g r a p h i c a n d c l i n i c a l c h a r a c t e r i s t i c s 
o f t h e 65 p a t i e n t s w i t h RA 
Number o f 
Patients 
(N = 65) Percent 
Sex 
M a l e 
F c m a l c 
A g e group 
< 50 
51 to 60 
61 to 70 
> 70 
Funct ional class A C R 
I 
IV 
Rheumatoid l'actor 
(Singer P lö t z , N = 64) 
Negat ive 
Posi t ive 
23 
42 
18 
10 
20 
17 
10 
19 
34 
2 
31 
33 
35 .4 
64 .6 
27 .7 
15.4 
30 .8 
26 .2 
15.4 
29 .2 
52.3 
3.1 
48 .6 
51 .6 
from further consideration. After standardization of individu-
al scores, the index was calculated as the mean of the stan-
dardized scores. The internal consistency of this index was 
0.97. which we considered higher than required. We there -
fore dropped 2 joints from the lower extremity to balance 
the number of measurements of the upper and lower extremi-
ties. Because measurements of the knees were easier and 
faster to obtain than for the hip and anklc joints, the knee 
was selected. The internal consistency of this füll M S I meas-
uring the strength of the knee and elbow joints (flexion and 
extension, both sides; 8 measurements) was 0.95. The corre-
lations of the selected muscle strength measurements ofthe 
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füll version are shown in Tables 2 and 3. A s an alternative 
to the füll M S I , we also tested a short version using only 
measurements from the right side (elbow and knee, exten-
sion and flexion; 4 measurements). The internal consistency 
was 0.92 and the correlation between the measurements 
ranged from 0.64 (between flexion of the knee and exten-
sion of the elbow) to 0.85 (between flexion and extension 
of the elbow). 
As expected, body height was a moderate correlate of both 
strength indices (r = 0.33, p < 0.01). Sex did not reach 
Statistical significance (füll version: p = 0.12; short version: 
p = 0.19). Age and weight were not corrclated with strength 
in our population. 
Test-retest r e l i a b i l i t y . The average intraobserver reliability 
ofthe individual muscle measurements was 0.94 (p < 0.01) 
with a ränge of 0.84 to 0.98. The average interobserver relia-
bility was 0.94 (p < 0.01) ranging from 0.78 to 0.98. 
V a l i d i t y . The correlation of the füll M S I with variables of 
disease activity and disease activity are shown in Table 3. 
The correlations of the short index were virtually identical 
and differed less than 5% from the füll index. The M S I was 
most strongly correlated with grip strength (r = 0.61. p < 
0.01) (Table 4). The correlation with variables of disease 
activity was moderate and ranged from 0.24 (swollen Joint 
count; p = 0.05) to 0.37 (ESR; p < 0.01). The correlation 
with pooled indices of disease activity was - 0 . 6 8 (p < 0.01) 
for the Mal lya index and - 0 . 3 7 (p < 0.01) for the D A S . 
Correlations with the Larsen score were 0.51 (p < 0.01) 
and 0.63 (p < 0.01) with the H A Q . 
C o n t r i b u t i o n o f s t r e n g t h i n e x p l a i n i n g V a r i a t i o n o f disease 
a c t i v i t y . Muscle strength was a significant variable (p < 
0.01) when added to a model with swollen and tender Joint 
count (raising the R-square of the model from 32 to 40%) , 
with physician's global disease activity assessment as the de-
pendent variable. Muscle strength was also significant (p < 
0.05) when added to a model with the 2 articular indices and 
E S R or C R P and increased the V a r i a t i o n of overall disease 
activity cxplained from 37 to 43% and from 36 to 4 3 % , 
respectively. 
In a model that included the variables ofthe D A S , the M S I 
strength was a significant correlate (p < 0.05). The addi-
tion of the M S I to the model increased the explained V a r i a -
tion from 52 to 56%. In a stepwise forward selection process 
ofthe D A S variables and the M S I , the Ritchie articular index 
was chosen first and explained 27% of the Variation of dis-
ease in addition to the variables forced to stay in the model 
(age, body height and sex; explaining 9% ofthe V a r i a t i o n ) . 
The M S I was selected second and explained an additional 
10%. E S R was selected third and explained an additional 
5% resulting in a model R-square of 53%. Global health and 
swollen Joint count did not reach Statistical significance. 
When grip strength instead of the M S I was added to the 
model, this was not statistically significant. In a stepwise for-
ward selection together with the 4 D A S variables, grip 
strength was not selected (variables selected included the 
Ritchie articular index, E S R and global health explaining 
51% of the V a r i a t i o n of physician's activity estimate). 
The M S I but not grip strength was a significant explana-
tory variable (p < 0.05) when added to a model with the 
variables from the van R i c l index (increasing the R Square 
of the model from 36 to 40%). In a stepwise forward selec-
tion of the van Riel variables, the M S I was selected second 
(after tender Joint count) explaining 10%' ofthe V a r i a t i o n of 
disease activity. 
Table 2. C o r r e l a t i o n s between muscle s t r e n g t h measurements o f t h e r i g h t s i d e 
Joint Right Knee Right E l b o w 
Func t ion Extens ion F l e x i o n Extens ion F l e x i o n 
Right knee Extens ion 1 
F l e x i o n 0.81 1 
Right elbow Extens ion 0.68 0.64 1 
F l e x i o n 0 .77 0 .73 0.85 1 
A l l Spearman correlations have a p value < 0 .01 . 
Table 3 C o r r e l a t i o n s between muscle s t r e n g t h measurements o f b o t h body sides 
Joint 
Func t ion 
Right Knee 
Extens ion F l e x i o n 
Right E l b o w 
Extens ion F lex ion 
Left knee Extens ion 0.81 
F l e x i o n 0.87 0.90 
Left e lbow Extens ion 0.70 0.65 0.87 
F l e x i o n 0.74 0.65 0.57 0 .69 
A l l Spearman correlations have a p value < 0 .01 . 
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Table 4. R e l a t i o n s h i p o f t h e muscle s t r e n g t h i n d e x (MSI) w i t h 
disease a c t i v i t y a n d d i s e a sc s e v e r i t y v a r i a b l e s 
Var iab le Med ian Corre la t ion with 
(Quartiles) M S I * 
S w o l l e n Joint count 5 (2:1 1) - 0 . 2 4 
Tender Joint count 6 (2;15) - 0 . 3 1 * * 
Ri tch ie ar t icular index 18.5 (8;38.5) - 0 . 2 9 * * 
G r i p strength ( k p / c n r ) 0.61 (0.39:0.45) 0.61* 
Pain (0-10) 5 (3:6) - 0 . 4 2 * 
C R P (mg/dl) 1.8 (0:4.6) - 0 . 3 4 ' 
H S R (mm/h) 18 (12:30) - 0 . 3 7 * 
Phys i c i an ' s act ivi ty estimate (0- 10) 3 ( 2 : 5 ) - 0 . 4 7 t 
G l o b a l health (0-3) 2 (1:2) - 0 . 4 2 * 
Larsen-score (0-40) 10 (8:17.5) - 0 . 5 1 * 
Heal th assessment 
questionnaire (0-3) 1.19 (0.25:1.75) - 0 . 6 3 * 
Disease durat ion (years) 5.2 (1.44:11.6) 0 .30** 
* Spearman correlat ion coefficient. 
** p < 0 .05 : * p < 0 .01 . 
If added to a model with all variables but grip strength 
from the M a l l y a index, the MSI did not reach Statistical sig-
nificance (p = 0.08). In a model of all 6 original Mal lya 
variables (including grip strength). grip strength was not sig-
nificant (p = 0.48). In a forward stepwise selection process, 
the M S I was selected 4th (after pain, hemoglobin and the 
Ritchie articular index) but did not reach S t a t i s t i c a l sig-
nificance (p = 0.07). Gr ip strength was not selected in a 
similar process. 
DISCUSSION 
Muscle strength in patients with R A can be mcasured reli-
ably with a simple hand held pull gauge. Muscle measure-
ments obtained at different Joint sites have a high correla-
tion, and the aggregation of measurements into an index has 
a high internal consistency. Becausc of frequent impairment 
of the wrist and Shoulder joints which interfered with the 
measurement of muscle strength, practica] aspects and the 
goal of balancing the number of measurements of the upper 
and lower extremity. we suggest that measurements of ex-
tension and flexion ofthe elbow and knee joints be included 
in the index. A short version with 4 measurements includ-
ing only one body side had only a slightly smaller internal 
consistency and may be the optimal compromise between 
Statistical stability and efficiency. 
A s expected, we found isometric muscle strength to be 
associated with body height. In our population with rclatively 
little age Variation, age was not associated with isometric 
muscle strength. Sex was not significant in univariate analy-
sis, an indication that other factors such as body height and 
disease activity were more important. Nevertheless, in studies 
using muscle strength as an outcome variable involving 
groups with unequal distribution of these characteristics, it 
is advisable to control for age, sex and body height. 
Muscle strength correlates with generally aeeepted varia-
bles o f disease activity and pooled disease activity indices 
such as the D A S , the van Riel and the M a l l y a index. The 
particularly high correlation with the Ma l lya index may be 
explained by the fact that this index includes grip strength. 
Using physician's global assessment of disease activity as 
an external S t a n d a r d , the M S I provides Information in addi-
tion to articular indices and the ESR or C R P . It also increases 
the V a r i a t i o n in disease activity explained by the variables 
included in the D A S and van Riel indices. When added to 
the variables of the Mal lya index (without grip strength), the 
MSI did not reach significance. Whether this is due to a limit-
ed power in the small sample or whether the M S I does not 
provide additional Information when morning stiffness and 
pain are included in a disease activity index cannot be decided 
on the basis of our data. It is striking that grip strength did 
not add information to the variables ofthe D A S , the van Riel 
or the Mal lya index. This Unding is consistent with the non-
selcction of grip strength into the statistically derived D A S . 
The M S I therefore may have advantages over grip 
strength. First , measurements of knee and elbow strength 
were obtainable in cases where deformities o f the hand in-
terfered with grip strength measurement. Even in the case 
of one immobile Joint, the M S I can still be calculated and 
provides a stable estimate because ofthe aggregation of stan-
dardized measurements. Second, unlike grip strength. the 
M S I seems to provide additional information when used with 
composite disease activity indices. Third. the MSI may reflect 
the systemic nature of R A better than grip strength because 
it includes measures of both the upper and lower extremity 
and may thus improve the content validity of a disease activity 
index. Whether the MSI should be considered for inclusion 
in a disease activity index is. however, conditional on its sen-
sitivity to change. Prospective data on sensitivity are 
underway. 
Eike grip strength'1', the MSI is not exclusively a meas-
ure of disease activity but also of disease severity. It may 
thus be a useful measure of impairment in addition to physi-
cal functional disability and radiological destruetion in 
assessing the cumulative impact of disease. 
In conclusion. the M S I is a reliable and valid measure of 
disease activity. Unl ike grip strength, it may improve the 
content validity of pooled disease activity indices and may 
be a particularly useful impairment measure for the assess-
ment of longterm treatment Effects. The external validity in 
other populations with R A and the responsiveness ofthe MSI 
need to be established. 
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